Clinical Investigation to Evaluate the Safety and Performance of ConnettivinaBio Plus Cream Compared to ConnettivinaBio Cream in the Management of Wounds in Patients at High Risk of Infection

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

April 30, 2024

Study Completion Date

December 31, 2024

Conditions
Wounds
Interventions
DEVICE

ConnettivinaBio Plus cream

The Un-blinded Investigator will perform the first application of medication. He will also instruct the patient or his/her caregiver to the self-application of the treatment which will be covered by a secondary dressing according to the site's standard care.

DEVICE

ConnettivinaBio cream

The Un-blinded Investigator will perform the first application of medication. He will also instruct the patient or his/her caregiver to the self-application of the treatment which will be covered by a secondary dressing according to the site's standard care.

Trial Locations (1)

Unknown

RECRUITING

Casa di Cura Villa Donatello, Florence

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY